When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing? [0.03%]
何时应对肿瘤基因组检测结果进行遗传咨询？
Kim DeLeonardis,Lauren Hogan,Stephen A Cannistra et al.
Kim DeLeonardis et al.
Somatic genomic testing is rapidly becoming an integral part of care for patients with metastatic cancer. Extrapolation of these results beyond personalized cancer therapy is a skill being demanded of practicing oncologists without prior sp...
Tumor Genomic Sequencing as an Impetus to Screen for Germline Mutations: Primum Non Nocere [0.03%]
肿瘤基因组测序筛查遗传性变异的机遇与挑战——首先不伤害
Saroj Niraula
Saroj Niraula
"My Family Wants Something Different": Discordance in Perceived Personal and Family Treatment Preference and Its Association With Do-Not-Resuscitate Order Placement [0.03%]
“我的家人想要不同的治疗”——个人与家庭成员的治疗意愿不一致及其对“不做心肺复苏决定”的影响
Login S George,William Breitbart,Holly G Prigerson
Login S George
Purpose: Patients make treatment decisions based not only on what they want, but what they think their families want. Discordance in such perceived preferences may therefore pose challenges for advance care planning. This...
Patient Navigation in Cancer: The Business Case to Support Clinical Needs [0.03%]
癌症患者导航：支持临床需求的商业案例分析
Ronald M Kline,Gabrielle B Rocque,Elizabeth A Rohan et al.
Ronald M Kline et al.
Purpose: Patient navigation (PN) is an increasingly recognized element of high-quality, patient-centered cancer care, yet PN in many cancer programs is absent or limited, often because of concerns of extra cost without ta...
Real-World Clinical and Economic Outcomes and the Role of Bevacizumab in Patients With Non-Small-Cell Lung Cancer With Liver Metastases [0.03%]
贝伐单抗在非小细胞肺癌肝转移患者中的临床和经济效益及作用分析
William B Wong,Ning Wu,Erru Yang et al.
William B Wong et al.
Purpose: Liver metastases are associated with poor outcomes in patients with advanced non-small-cell lung cancer (aNSCLC). Nevertheless, the vasculature in the liver microenvironment may be conducive to the use of antiang...
Parth K Modi,Samuel R Kaufman,Lindsey A Herrel et al.
Parth K Modi et al.
Purpose: We describe the longitudinal adoption of conservative management (ie, the absence of treatment) for prostate cancer among urology group practices in the United States and identify group practice features that inf...
Daniel C McFarland,Fay J Hlubocky
Daniel C McFarland
Has There Been a Shift in Use of Subacute Rehabilitation Instead of Hospice Referral Since Immunotherapy Has Become Available? [0.03%]
免疫治疗问世以来姑息治疗的使用情况发生了变化吗？
Jonathan C Yeh,Louise S Knight,Joyce Kane et al.
Jonathan C Yeh et al.
Purpose: Immunotherapy has rapidly become the mainstream treatment of multiple cancer types. Since the first drug approval in 2011, we have noted a decline in referrals from inpatient oncology to hospice and an increase i...
Estimated Cost and Savings in a Patient Management Program for Oral Oncology Medications: Impact of a Split-Fill Component [0.03%]
口腔肿瘤药物患者管理项目的成本和节约估算：分剂量成分的影响
Francis C Staskon,Heather S Kirkham,Amy Pfeifer et al.
Francis C Staskon et al.
Purpose: A national specialty pharmacy implemented a split-fill option within an oral oncology patient management program to reduce pharmacy costs and medication wastage resulting from early discontinuations. Payers cover...
Concerns of Patients With Cancer on Accessing Cannabis Products in a State With Restrictive Medical Marijuana Laws: A Survey Study [0.03%]
限制性大麻药理法规状态下癌症患者获取大麻产品的顾虑：一项调查研究
Vinita Singh,Ali J Zarrabi,Kimberly A Curseen et al.
Vinita Singh et al.
Purpose: Several states, particularly in the Southeast, have restrictive medical marijuana laws that permit qualified patients to use specific cannabis products. The majority of these states, however, do not provide avenu...